Finally, we demonstrate that a dual CHEK1/2 inhibitor known to sensitize cancer cells to chemotherapy significantly improved primordial oocyte survival after treatment with radiation or alkylating agents ex vivo, suggesting that this class of cancer drugs could have an additional, beneficial effect against chemotherapy-induced ovarian toxicity. The gene discussed is CHEK1; the disease is cancer.